COVID-19 and Rare Skin Diseases European Observational Study During an Epidemic
NCT04451902 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2021-09-02
Summary
This is a European observational cohort study (data research) involving multiple centres to look at the potential impact of COVID infection on patients with rare skin diseases examining factors such as comorbidity, protection factors, and clinical and/or therapeutic factors. The data collected may provide additional information on the situation of patients and, on a wider basis, provide useful data applicable to the general population.
Conditions
Sponsors & Collaborators
-
Imagine Institute
lead OTHER
Principal Investigators
-
Christine BODEMER · Hôpital Necker-Enfants Malades
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-30
- Primary Completion
- 2022-04-30
- Completion
- 2022-12-31
Countries
- Czechia
- France
- Germany
- Italy
- Lithuania
Study Locations
More Related Trials
-
LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice
NCT07336641 ·Status: NOT_YET_RECRUITING
-
Investigating Healthcare Disparities in Vitiligo
NCT06097494 ·Status: COMPLETED
-
Personalized Therapy of Patients Suffering From Rare Genodermatoses
NCT05680974 ·Status: UNKNOWN
-
Evaluation and Treatment of Patients With Dermatologic Diseases
NCT00001506 ·Status: COMPLETED
-
Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome
NCT02550080 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Scaling Disorders and Other Inherited Skin Diseases
NCT00001292 ·Status: COMPLETED
-
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
NCT06602232 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
NCT00936546 ·Status: COMPLETED ·Phase: PHASE2
-
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
NCT06599411 ·Status: NOT_YET_RECRUITING
-
The Acquisition of Blood and Skin Samples From Normal Volunteers to Support Research Activities on Dermatologic Diseases
NCT00001505 ·Status: COMPLETED
-
Assessment of Dermatologists at Skin of Color Clinics
NCT03201029 ·Status: COMPLETED
-
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
NCT07021495 ·Status: RECRUITING
-
SARCOTHAL. Thalidomide in Skin Sarcoidosis
NCT00305552 ·Status: COMPLETED ·Phase: PHASE3
-
Prevalence and Subjective Impairment of Quality of Life (QoL) Due to Dermatologic Diseases in Internal Medicine Patients
NCT01044043 ·Status: COMPLETED
-
Assessment of the Rosacea Prevalence in the General Population
NCT02292797 ·Status: COMPLETED
-
Digital Toolkit for Skin Diseases in LMICs: Part 2
NCT06292260 ·Status: RECRUITING ·Phase: NA
-
Mycophenolate in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot)
NCT04927390 ·Status: UNKNOWN ·Phase: PHASE2
-
Vitiligo Treatment by Targeting TYK2 Mediated Responses
NCT06327321 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study to Test Genetic Alterations Among Different Dermoscopic Types of Melanocytic Nevi.
NCT00422448 ·Status: COMPLETED ·Phase: NA
-
Determinants of Chronic Inflammatory Skin Disease Trajectories
NCT05928169 ·Status: RECRUITING
-
Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions
NCT03198390 ·Status: TERMINATED
-
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata
NCT03976622 ·Status: UNKNOWN
-
Melanin Index in Those With Fitzpatrick Skin Phototypes I-VI
NCT01124513 ·Status: COMPLETED ·Phase: NA
-
FARD (RaDiCo Cohort) (RaDiCo-FARD)
NCT05954416 ·Status: RECRUITING
-
A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome
NCT05979831 ·Status: TERMINATED ·Phase: PHASE1/PHASE2